Initial Diagnosis and Treatment of Low-Risk Gestational Trophoblastic Neoplasia

被引：0
|
作者：
Alimena, Stephanie [1 ,2 ,3 ]
Elias, Kevin M. [1 ,2 ,3 ]
Horowitz, Neil S. [1 ,2 ,3 ]
Berkowitz, Ross S. [1 ,2 ,3 ]
机构：
[1] Brigham & Womens Hosp, Dept Obstet & Gynecol, Div Gynecol Oncol, Boston, MA 02115 USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Harvard Med Sch, Boston, MA 02115 USA
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2024年 / 38卷 / 06期
关键词：
Gestational trophoblastic neoplasia; Low risk; Chemotherapy; Methotrexate; Dactinomycin; Immunotherapy; Hysterectomy; Second dilation and curettage; ACTINOMYCIN-D; FOLINIC ACID; METHOTREXATE INFUSION; PULSE DACTINOMYCIN; PRIMARY THERAPY; DISEASE; CHEMOTHERAPY; MANAGEMENT; EXPERIENCE; RESISTANCE;
D O I：
10.1016/j.hoc.2024.07.005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Though low-risk GTN is a highly curable disease, due to strong productive research, we can continue to advance understanding of how to minimize relapses, lessen toxicity of treatment, and help women to maintain their quality of life and fertility after treatment for GTN.
引用
收藏
页码：1233 / 1244
页数：12
相关论文
共 50 条
  • [41] Differences in Administration of Methotrexate and Impact on Outcome in Low-Risk Gestational Trophoblastic Neoplasia
    Wallin, Emelie
    Niemann, Isa
    Faaborg, Louise
    Fokdal, Lars
    Joneborg, Ulrika
    CANCERS, 2022, 14 (03)
  • [42] A cost minimization analysis of first-line treatment strategies for low-risk gestational trophoblastic neoplasia
    Shah, N.
    Barroilhet, L.
    Berkowitz, R.
    Feltmate, C.
    Muto, M.
    Goldstein, D.
    Horowitz, N.
    GYNECOLOGIC ONCOLOGY, 2011, 121 (01) : S116 - S116
  • [43] Low-risk gestational trophoblastic neoplasia outcome after treatment with VMP regimen from 2005 to 2017
    Zhu, Chen-Chen
    Liu, Han-Yuan
    Wei, Ying
    Shen, Zhen
    Qian, Li-Li
    Song, Wei-Guo
    Wang, Juan
    Wu, Da-Bao
    Zhang, Xue-Fen
    Zhou, Ying
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2019, 58 (03): : 332 - 337
  • [44] Diagnosis, classification and treatment of gestational trophoblastic neoplasia
    Biscaro, Andressa
    Braga, Antonio
    Berkowitz, Ross Stuart
    REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2015, 37 (01): : 42 - 51
  • [45] Postmolar choriocarcinoma: An independent risk factor for chemotherapy resistance in low-risk gestational trophoblastic neoplasia
    Strohl, Anna E.
    Lurain, John R.
    GYNECOLOGIC ONCOLOGY, 2016, 141 (02) : 276 - 280
  • [46] Comparison of methotrexate, actinomycin D, and etoposide for treating low-risk gestational trophoblastic neoplasia
    Baptista, Angela M.
    Belfort, Paulo
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2012, 119 (01) : 35 - 38
  • [47] Immunotherapy Versus Chemotherapy for Methotrexate-Resistant Low-Risk Gestational Trophoblastic Neoplasia
    Lurain, John R.
    Schink, Julian C.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (36) : 4349 - +
  • [48] PLACENTA ACCRETA AFTER REMISSION OF LOW-RISK GESTATIONAL TROPHOBLASTIC NEOPLASIA: A CASE REPORT
    Mukouyama, Fumitaka
    Omoto, Akiko
    Shinno, Rie
    Nagasawa, Akiko
    Hirosawa, Akiko
    Suzuki, Yoshiya
    Okayama, Jun
    Nakada, Emiri
    Sato, Asuka
    Usui, Hirokazu
    Shozu, Makio
    PLACENTA, 2021, 103 : 248 - 249
  • [49] A Cost Analysis of First-Line Chemotherapy for Low-Risk Gestational Trophoblastic Neoplasia
    Shah, Neel T.
    Barroilhet, Lisa
    Berkowitz, Ross S.
    Goldstein, Donald P.
    Horowitz, Neil
    JOURNAL OF REPRODUCTIVE MEDICINE, 2012, 57 (5-6) : 211 - 218
  • [50] Consolidation chemotherapy in postmolar low-risk gestational trophoblastic neoplasia: a systematic review protocol
    Branco-Silva, Mariza
    Maesta, Izildinha
    Elias, Kevin
    Berkowitz, Ross Stuart
    Abbade, Joelcio Francisco
    Horowitz, Neil S.
    BMJ OPEN, 2022, 12 (02):
12345